Skip to main content
Top

PharmacoEconomics

Issue 9/2019

Content (8 Articles)

Open Access Original Research Article

Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations

Mario J. N. M. Ouwens, Pralay Mukhopadhyay, Yiduo Zhang, Min Huang, Nicholas Latimer, Andrew Briggs

Original Research Article

Mapping the PedsQL™ onto the CHU9D: An Assessment of External Validity in a Large Community-Based Sample

Christine Mpundu-Kaambwa, Gang Chen, Elisabeth Huynh, Remo Russo, Julie Ratcliffe

Open Access Original Research Article

Severity-Adjusted Probability of Being Cost Effective

Matthijs M. Versteegh, Isaac Corro Ramos, Nasuh C. Buyukkaramikli, Amir Ansaripour, Vivian T. Reckers-Droog, Werner B. F. Brouwer

Open Access Original Research Article

Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe

Dominik Golicki, Michał Jakubczyk, Katarzyna Graczyk, Maciej Niewada

Open Access Acute Lymphoblastic Leukemia Original Research Article

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States

Thomas E. Delea, Xinke Zhang, Jordan Amdahl, Diana Boyko, Franziska Dirnberger, Marco Campioni, Ze Cong